<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04856709</url>
  </required_header>
  <id_info>
    <org_study_id>Pectopexy</org_study_id>
    <nct_id>NCT04856709</nct_id>
  </id_info>
  <brief_title>Abdominal Pectopexy Versus Abdominal Sacral Hysteropexy.</brief_title>
  <official_title>Abdominal Pectopexy Versus Abdominal Sacral Hysteropexy as Conservative Surgeries for Genital Prolapse: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare between abdominal pectopexy and abdominal sacral hysteropexy in&#xD;
      terms of efficacy (assessed by POP-Q system), intra and postoperative complications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pelvic organ prolapse (POP), the herniation of the pelvic organs to or beyond the vaginal&#xD;
      walls, is a common condition. Many women with prolapse experience symptoms that impact daily&#xD;
      activities, sexual function, and exercise. The presence of POP can have a detrimental impact&#xD;
      on body image and sexuality (Lowder et al., 2011). Nulliparous prolapse is reported to&#xD;
      account for 1.5% to 2% of all cases of genital prolapse (Virkud, 2016). The incidence rises&#xD;
      to 5 -8 % for young women who have delivered one or two children. As this type of prolapse&#xD;
      occurs at a younger age, the surgical technique should not only reduce the prolapse but also&#xD;
      retain the reproductive function. Various conservative surgeries have been described in the&#xD;
      past, each having their own merits and de-merits (Rameshkumar et al., 2017).&#xD;
&#xD;
      Pelvic organ prolapse (POP) is affecting women of all ages. Epidemiological studies suggest a&#xD;
      lifetime risk of prolapse or incontinence surgery of between 7 and 19% (Olsen et al., 1997;&#xD;
      Smith et al., 2010). In an ageing population, the incidence of these surgeries would only be&#xD;
      expected to increase, although the increasing Caesarean Section rates and smaller family size&#xD;
      in recent years will have a negative impact on the prevalence of these conditions. There are&#xD;
      many approaches to the surgical correction of POP, which frequently reflect the nature and&#xD;
      anatomical site of the defective support, but essentially the surgeon has to decide whether&#xD;
      to perform this surgery vaginally or via the abdomen as an open or laparoscopic procedure. If&#xD;
      performed vaginally, further decisions regarding the use of synthetic or biological graft to&#xD;
      reinforce the repair need to be made (Cvach and Dwyer, 2012).&#xD;
&#xD;
      Pectopexy is a new technique for apical repair in which lateral parts of the iliopectineal&#xD;
      ligament are used for cuff or cervix suspension. This new method is considered a simple, safe&#xD;
      procedure, especially in patients whose surgical exploration is difficult (Banerjee and Noé,&#xD;
      2011).&#xD;
&#xD;
      This method uses the iliopectineal ligament on both sides for the mesh ﬁxation, (Banerjee and&#xD;
      Noé, 2011). so there is no restriction caused by the mesh. The mesh follows natural&#xD;
      structures (round and broad ligaments) without crossing sensitive spots, such as the ureter&#xD;
      or bowel. The hypogastric trunk is at a safe distance and out of danger.&#xD;
&#xD;
      The iliopectineal ligament is an extension of the lacunar ligament that runs on the pectineal&#xD;
      line of the pubic bone (Faure et al., 2001), and is significantly stronger than the&#xD;
      sacrospinous ligament and the arcus tendineus of the pelvic fascia (Cosson et al., 2003). The&#xD;
      structure is strong, and holds suture well Abdominal sacral hysteropexy remains a viable&#xD;
      alternative for women undergoing pelvic reconstructive surgery who wish to retain their&#xD;
      uteri, providing comparable rates of overall improvement and symptom change. Avoiding&#xD;
      hysterectomy decreases the risk of mesh erosion but may increase the risk of subsequent&#xD;
      recurrent prolapse, specifically in the anterior compartment (Cvach and Cundiff, 2008).&#xD;
&#xD;
      Although sacrocolpopexy has been the most effective option over time, the procedure is still&#xD;
      associated with some problems, and the most frequently reported complications include&#xD;
      defecation disorders and stress urinary incontinence (SUI)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Actual">April 1, 2021</completion_date>
  <primary_completion_date type="Actual">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Study design: Randomized Controlled clinical Trial&#xD;
Study Setting: Ain Shams maternity hospital.&#xD;
Study Population: The study included 80 women divided into 2 groups:&#xD;
Group A: 40 women underwent abdominal pectopexy. Group B: 40 women underwent abdominal sacral hysteropexy.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy, After the procedure there will be follow up visits at 3 months to detect the efficacy of the procedure by using POP-Q system.</measure>
    <time_frame>3 months</time_frame>
    <description>The POP-Q system is a technique that measures compartment prolapse relative to the anatomic landmark of the hymen.Prolapse points proximal to the hymen are given a negative value, whereas positive values are given to points that protrude past the hymen. 6 points are delineated, including two on the anterior vaginal wall (Aa, Ba), two on the vaginal apex (C, D), and two on the posterior vaginal wall (Ap, Bp). Points Gh, Pb, and TVL describe the genital hiatus, perineal body, and total vaginal length, respectively.&#xD;
Stage 0: no demonstrable prolapse&#xD;
Stage 1: the most distal portion of the prolapsed segment is &gt;1 cm above the level of the hymen&#xD;
Stage 2: the most distal portion of the prolapsed segment is &gt;1 cm or less proximal or distal to the hymen&#xD;
Stage 3: the most distal portion of the prolapsed segment protrudes &gt;1 cm below the hymen but 2 cm less than the total length of the vagina&#xD;
Stage 4: complete eversion of the vagina</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>60- 240 minutes</time_frame>
    <description>Total operative time from skin incision till closure of the skin and excluding time of concomitant surgical procedures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra operative blood loss</measure>
    <time_frame>60- 240 minutes</time_frame>
    <description>Intra operative blood loss will be estimated via:&#xD;
Amount of blood in suction bottle. Drop in postoperative hemoglobin and hematocrit when compared with preoperative values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra operative complications</measure>
    <time_frame>60- 240 minutes</time_frame>
    <description>Intra operative complications including:&#xD;
Need for blood transfusion.&#xD;
Bowel or bladder injury.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative complications</measure>
    <time_frame>1 week</time_frame>
    <description>Subfascial hematoma or pelvic hematoma.&#xD;
Surgical site infection.&#xD;
Urinary tract infection.&#xD;
Need for post-operative blood transfusion.&#xD;
Postoperative bowel or urinary tract complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative pain</measure>
    <time_frame>after 6 hours, 12 hours and 24 hours from the operation</time_frame>
    <description>Postoperative pain will be assessed using the linear 10cm visual analogue scale. Range is from 10(unbearable pain) to zero (no pain).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Genital Prolapse</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women with stage 2 to 4 uterine prolapse. BMI from ≤ 35 kg\m2. Women of any parity including nulliparas will be included. Age of female patients ranges from 20 to 40 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Abdominal Pectopexy</intervention_name>
    <description>Pectopexy is a new technique for apical repair in which lateral parts of the iliopectineal ligament are used for cuff or cervix suspension.</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Abdominal Sacral Hysteropexy</intervention_name>
    <description>Abdominal sacrocolpopexy is a procedure that uses a mesh material to support the top of the vagina to treat pelvic prolapse.</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with stage 2 to 4 uterine prolapse.&#xD;
&#xD;
          -  BMI from ≤ 35 kg\m2.&#xD;
&#xD;
          -  Women of any parity including nulliparas will be included.&#xD;
&#xD;
          -  Age of female patients ranges from 20 to 40 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous correction of apical prolapse.&#xD;
&#xD;
          -  Inoperable co-existing uterine pathology&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of medicine, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11591</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>6 months after publication</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

